Zymeworks Inc (ZYME) financials
Zymeworks revenue and earnings by year
Zymeworks's revenue was $106 million in the fiscal year to December 31, 2025, up 38.9% from the year before. Net income was -$81.1 million, -76.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 28.6% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 106 | 76 | 76 | 412 | 27 | 39 | 30 | 53 | 52 | 11 |
| Revenue growth | 38.9% | 0.4% | -81.6% | 1446.0% | -31.5% | 31.8% | -44.3% | 2.4% | 370.2% | — |
| Operating income | -93 | -137 | -138 | 131 | -216 | -187 | -151 | -33 | -9 | -38 |
| Operating margin | -87.3% | -179.7% | -181.6% | 31.6% | -808.2% | -481.3% | -512.1% | -62.9% | -18.3% | -343.9% |
| Net income | -81 | -123 | -119 | 124 | -212 | -181 | -145 | -37 | -10 | -34 |
| Net margin | -76.6% | -160.8% | -156.1% | 30.1% | -794.0% | -463.5% | -492.3% | -68.9% | -20.1% | -307.1% |
| Diluted EPS | -$1.08 | -$1.62 | -$1.72 | $1.90 | -$4.61 | — | -$3.83 | -$1.26 | — | — |
| Free cash flow | -35 | -112 | -121 | 136 | -205 | -156 | -88 | 23 | -2 | -40 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ZYME in Markets.
See also: ZYME returns
No forecast, no recommendation. This page describes Zymeworks Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.